INTEGRATED PATIENT MANAGEMENT AND CONTROL SYSTEM FOR MEDICATION DELIVERY

• US 20100273738A1
• Filed: 04/22/2010
• Published: 10/28/2010
• Est. Priority Date: 04/23/2009
• Status: Abandoned Application

• Current Assignee: Automedics Medical Systems, Inc.
• Original Assignee: Automedics Medical Systems, Inc.
• Inventors: VALCKE, CHRISTIAN P., Gorin, Michael, Gharib, James E.
• Application Number:
  US12/765,678
• Publication Number:
  US 20100273738A1
• Time in Patent Office: Days
• US Class Current: 514/56
• CPC Class Codes: A61B 5/02152 specially adapted for venous pressure
• CPC Class Codes: A61B 5/0225 the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/15003 for venous or arterial blood
• CPC Class Codes: A61B 5/150213 Venting means
• CPC Class Codes: A61B 5/150358 Strips for collecting blood, e.g. absorbent optical reagent test strips G01N21/8483; chemical reagent test strips G01N33/4875, G01N33/52
• CPC Class Codes: A61B 5/15074 Needle sets comprising wings, e.g. butterfly type, for ease of handling
• CPC Class Codes: A61B 5/150786 Optical identification systems, e.g. bar codes, colour codes
• CPC Class Codes: A61B 5/155 Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals devices loaded with multiple lancets simultaneously A61B5/15146
• CPC Class Codes: A61B 5/157 Devices characterised by integrated means for measuring characteristics of blood
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/18 with alarm
• CPC Class Codes: A61M 2205/6054 Magnetic identification systems
• CPC Class Codes: A61M 2205/6063 Optical identification systems
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders

Abstract

An integrated patient monitoring and control system is provided which includes a closed-loop control system for monitoring and adjusting the heparin infusion rate for a patient. The system includes a processor which uses a dynamic patient model that is continuously adjusted based on the patient'"'"'s aPTT measurements to calculate an optimal heparin infusion rate to achieve an operator-input aPTT target range. The processor also includes a forecasting model to calculate the optimum sample time interval for measuring the patient'"'"'s aPTT to calculate a new infusion rate. An automated sampling system, which includes a storage device for storing a series of assay devices, an advancement mechanism for moving the assay devices to a sample area, and a measurement device for analyzing a sample dispensed on the assay, is provided. The sampling system is used to repeatedly measure the patient'"'"'s aPTT according to the sample time interval determined by the processor.

Claims

1. A system for determining a diagnostic result from a fluid medium comprising:

a series of assay devices,

a measurement device to provide diagnostic results,

a storage device for said assay devices,

an advancement mechanism said assay devices through a sample application area, and

a mechanism for dispensing a fluid medium to an assay device.

2. The system of claim 1, further comprising an integrated waste area for collecting waste.

3. The system of claim 2, wherein the integrated waste area contains materials to absorb a liquid component of the waste.

4. The system of claim 1 wherein the set of assay devices comprise individual cartridges hermetically sealed inside of individual aluminum foiled pouches.

5. The system of claim 4, wherein the assay devices are integrated into a continuous strip.

6. The system of claim 1 wherein the measurement device comprises a source and/or sensor to measure an analyte in the fluid medium.

7. The system of claim 1 wherein the storage device for said assay devices comprises a framed structure for placement of said assay devices.

8. The system of claim 4 wherein the storage device further includes an optical reader of said assay device bar code.

9. The system of claim 1 wherein the advancement mechanism for said assay devices comprises an actuator that advances said assay device from storage device through a sample application area.

10. The system of claim 6 wherein the actuator is an electromechanical actuator.

11. The system of claim 6 wherein the actuator is a pneumatic actuator.

12. The system of claim 1 further comprising a mechanism for exposing an optical reading site on an assay device to a source of light and optical reader and the application site to a sample dispensing device, the mechanism comprising a mechanical device(s) that opens a moisture impermeable pouch and removes an assay device from said pouch.

13. The system of claim 12, wherein the mechanism for exposing an optical reading site on an assay device contained within a moisture impermeable pouch comprises aligning the optical reading site to the source of light by puncturing a seal in the pouch and exposing the optical reading site without removing the assay device from the pouch.

14. The system of claim 12 wherein the mechanism of exposing an optical reading site on an assay device contained within a moisture impermeable pouch to the source of light and optical reader and application site to a sample dispensing device comprises at least one mechanical device that opens the moisture impermeable pouch in said areas.

15. The system of claim 1, further comprising a removal mechanism for removing the assay device from the application area after completion of one diagnostic reading.

16. The system of claim 15 wherein the mechanism of removing said assay device from application area after completion of one diagnostic reading consists of an electromechanical or pneumatic device that deposits the cartridge to a waste reservoir.

17. A system for storing assay devices used to measure a diagnostic result in a fluid medium comprising:

a series of assay devices;

a storage device for said assay devices; and

an integrated waste area that contains materials to absorb a liquid component of a waste material.

23. The system of claim 17, wherein the advancement mechanism for the assay device consist of rotating mechanism delivering said assay devices to a sample application area.

24. The system of claim 23, wherein the rotating mechanism is a drum.

25. The system of claim 17 wherein the advancement mechanism for the assay devices consist of indexing mechanism delivering said assay devices to a sample application area.

26. The system of claim 25 wherein the indexing mechanism is a rack.

18. A system for determining activated partial thromboplastin time (aPTT) in a fluid medium employing a device comprising

a cassette containing a set of assay devices,

an aPTT measurement device,

an advancement mechanism for advancing said assay devices through a sample application area, and

a reservoir for collecting a liquid waste.

19. The system of claim 18, wherein the cassette contains a set of assay devices consisting of an optically clear support structure with individual nests for each individual said assay device.

20. The system of claim 19, wherein each assay device is hermetically sealed in own individual nest with optically clear plastic material.

21. The system of claim 19, wherein the support structure includes a drum.

22. The system of claim 19 wherein the support structure includes a rack.

27. A system for determining Prothrombin time (PT/INR) in a fluid medium employing a device comprising:

a cassette containing a set of assay devices;

a PT/INR measurement device;

an advancement mechanism for advancing said assay device to a sample application area; and

a reservoir for collecting a liquid waste.

28. A method for determining the infusion rate for delivering heparin to a patient comprising the steps of:

(a) obtaining a patient blood sample;

(b) measuring the patient'"'"'s Activated Partial Thromboplastin Time (aPTT);

(c) inputting the patient aPTT measurement into a processor;

(d) inputting an aPTT target for the patient into the processor; and

(e) using the processor to calculate a heparin infusion rate for the patient to achieve the target aPTT, the processor implementing a protocol including a dynamic patient model based on a pharmacodynamic model of heparin response that utilizes;

(i) the patient'"'"'s past history of infusion rates and

(ii) the current infusion rate

to calculate the heparin infusion rate.

29. The method of claim 28, further comprising reiteratively repeating steps (a)-(e) at selected intervals of time, wherein the dynamic patient model is adjusted to reflect the patient'"'"'s individualized heparin response.

30. The method of claim 29, wherein at least one parameter in the dynamic patient model is adjusted using Bayesian estimation to take into account the patient'"'"'s aPTT measurements.

31. The method of claim 29, wherein time interval for repeating steps (a)-(e) is predefined by the processor according to pharmacodynamic model of heparin response.

32. The method of claim 29, the time interval is reiteratively calculated after each repetition based on the adjusted dynamic patient model to take into account patient'"'"'s response to the current infusion rate.

33. The method of claim 29, wherein the protocol further includes a forecasting model for determining the confidence interval in the current estimated patient response and wherein the confidence interval is used to calculate the time interval for repeating steps (a)-(e).

34. The method of claim 28, further comprising adjusting the parameters of the dynamic patient model to reflect the patient'"'"'s individualized heparin response based on the patient'"'"'s measured aPTT and the current infusion rate.

35. The method of claim 28, wherein the dynamic patient model includes multiple parameters and wherein the protocol provides a non-linear input-output response.

36. The method of claim 28, wherein the dynamic patient model is updated after each heparin infusion to reflect patient'"'"'s individualized heparin response based on the patient'"'"'s measured aPTT and the current infusion rate.

37. The method of claim 28 further comprising:

calculating the optimal sampling time interval for re-measuring the patient'"'"'s aPTT.

38. The method of claim 28, further comprising triggering an alert/alarm in response to certain preset conditions.

39. The method of claim 38, wherein the preset conditions are selected from the following group consisting of:

when the patient test results are out of range for specified infusion rate, when the processor has not received sample input for certain period of time

40. The method of claim 38, wherein the alarm stops the delivery of heparin.

41. The method of claim 28, further comprising

initiating heparin delivery to a patient at a rate calculated by the processor;

monitoring the patient response to the heparin delivery, wherein the monitoring comprises taking a blood sample form the patient and measuring the patient'"'"'s aPTT according to a sampling frequency determined by the processor;

adjusting the dynamic patient model to reflect the patient'"'"'s individualized heparin response;

using the processor to calculate an updated heparin infusion rate based the revised protocol; and

adjusting the heparin delivery to the updated infusion rate.

42. A method for determining the sampling schedule for controlling the heparin delivery rate to a patient to maintain an optimal heparin delivery rate comprising the steps of:

(a) obtaining a patient blood sample;

(b) measuring the patient'"'"'s Activated Partial Thromboplastin Time (aPTT);

(c) inputting the patient aPTT measurement into a processor;

(d) inputting an aPTT target for the patient into the processor; and

(e) using the processor to calculate a time interval for re-measuring the patient'"'"'s aPTT to maintain an optimal infusion rate for the patient, the processor implementing a protocol including a dynamic patient model based on a pharmacodynamic model of heparin response that utilizes;

(i) the patient'"'"'s past history of infusion rates and

(ii) the current infusion rate

to calculate the optimal time interval for re-measuring the patient'"'"'s aPTT.

43. The method of claim 42, further comprising repeating steps (a)-(e), wherein the dynamic patient model is adjusted to reflect the patient'"'"'s individualized heparin response.

44. The method of claim 43, wherein adjusting the dynamic patient model comprises adjusting at least one parameter in the dynamic patient model using Bayesian estimation to take into account the patient'"'"'s aPTT measurements.

45. The method of claim 42, wherein the processor further includes a forecasting model for determining the confidence interval in a current estimated patient response and wherein the processor utilizes the confidence interval to calculate the time interval for the re-measuring the patient'"'"'s aPTT.

46. The method of claim 45, further comprising the step of inputting a maximum threshold for the confidence interval into the processor.

47. The method of claim 46, wherein the processor utilizes the threshold to calculate the time interval for re-measuring the patient'"'"'s aPTT.

48. The method of claim 45, further comprising reiteratively repeating steps (a)-(e) wherein the confidence interval is re-calculated after each patient aPTT measurement.